Indacaterol/Glycopyrronium improves pulmonary ventilation and ventilation inhomogeneity in the CLAIM Study

J. Vogel-Claussen (Hannover, Germany), T. Kaireit (Hannover, Germany), A. Voskrebenzev (Hannover, Germany), C. Schoenfeld (Hannover, Germany), C. Czerner (Hannover, Germany), J. Renne (Hannover, Germany), H. Tillmann (Basel, Switzerland), K. Berschneider (Nuremberg, Germany), S. Hiltl (Nuremberg, Germany), J. Bauersachs (Hannover, Germany), T. Welte (Hannover, Germany), J. Hohlfeld (Hannover, Germany)

Source: International Congress 2018 – COPD management
Session: COPD management
Session type: Thematic Poster
Number: 4388
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Vogel-Claussen (Hannover, Germany), T. Kaireit (Hannover, Germany), A. Voskrebenzev (Hannover, Germany), C. Schoenfeld (Hannover, Germany), C. Czerner (Hannover, Germany), J. Renne (Hannover, Germany), H. Tillmann (Basel, Switzerland), K. Berschneider (Nuremberg, Germany), S. Hiltl (Nuremberg, Germany), J. Bauersachs (Hannover, Germany), T. Welte (Hannover, Germany), J. Hohlfeld (Hannover, Germany). Indacaterol/Glycopyrronium improves pulmonary ventilation and ventilation inhomogeneity in the CLAIM Study. 4388

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: